Natus Medical Capital Expenditure Over Time

Natus Medical Incorporated -- USA Stock  

USD 40.1  0.2  0.5%

With this module investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well a as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets. Check also Natus Medical Performance and Natus Medical Correlation
  Refresh

Natus Medical Incorp and related stocks such as Edwards Lifesciences, EndoChoice Holdings Inc, Vascular Solutions Inc, Vaso, Digirad, and DarioHealth Corp Capital Expenditure Over Time

200620072008200920102011201220132014201520162017
(37.5 M)(57 M)(50.6 M)(64 M)(61.8 M)(76.6 M)(109 M)(109 M)(82.9 M)(102.7 M)(176.1 M)(146.7 M)
(690 K)(690 K)(690 K)(690 K)(690 K)(690 K)(690 K)(5 M)(10 M)(8.6 M)(8.6 M)(9.8 M)
(456.2 K)(1.5 M)(1.5 M)(1.3 M)(2.9 M)(2.4 M)(11.1 M)(4.2 M)(12.8 M)(13.4 M)(13.4 M)(13.8 M)
(320 K)(22.6 K)(22.6 K)(26 K)(135 K)(402 K)(402 K)(228 K)(365 K)(893 K)(893 K)(662.1 K)
(1.8 M)(8.6 M)(5.1 M)10 K(1.4 M)(709 K)(936 K)(726 K)(1.3 M)(1.4 M)(1.4 M)(1.4 M)
(534.6 K)(534.6 K)(534.6 K)(534.6 K)(534.6 K)(534.6 K)(534.6 K)(1.4 M)(563 K)(110 K)(110 K)(354.2 K)

Natus Medical Incorp and related stocks such as Edwards Lifesciences, EndoChoice Holdings Inc, Vascular Solutions Inc, Vaso, Digirad, and DarioHealth Corp Capital Expenditure description

A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived, physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.